Future chat group

The biggest difference between private equity financing and secondary market financing is the intensity of supervision. Listed companies have strict procedures. Private equity financing companies have not yet been listed, so investors need to pay more attention to the procedures.

On Monday the 25th, Lei Hao sent Lan Shijie and Zhao Lichen back to Yangcheng to reduce their positions and arbitrage on Nanyang Mining. He took a group of people to Danghe Pharmaceutical in Su City, Suzhou Province, intending to stay here for a while and take advantage of the situation. The work at this stage is completed.

The contract has been signed and all procedures have been completed. Now Lei Hao only needs to inject funds into the designated account. The project team he controls will become the major shareholder of Danghe Pharmaceutical, and he personally also holds 5% of the stock options. , can definitely be regarded as a big shot in this small pharmaceutical company.

What Lei Hao was not used to was that as the scale of assets he came into contact with and controlled gradually increased, Qiu Yuting, for some unknown reason, stuffed two bodyguards beside him.

"Brother Zheng and Brother Bu, let's not talk about their strength for now, but they look stylish when they are around." Just after getting off the plane, Lei Hao looked at the two bodyguards standing beside him and complained in his heart: "It's just that the names are too deceptive, Zheng Yimao ( Earn a dime)? Bu Chaosheng (not born)?"

Lei Hao was born in poverty. Although he was not used to the two bodyguards Qiu Yuting pushed over, his refusal to refuse had already shown something, that is...it is more honorable to have bodyguards.

After getting off the plane, with bodyguards clearing the way, Lei Hao felt vain. After seeing the personnel from Danghe Pharmaceutical who came to pick him up, he immediately put away his childishness and put on a serious face. face.

"Welcome, welcome. On behalf of all the employees of Danghe Pharmaceutical, I would like to welcome Mr. Lei to come to inspect the company." Kong Weixue, the general manager with no limits, personally led the team to pick up the plane, which showed that Danghe Pharmaceutical has high regard for Lei Hao and his team. of attention.

As general manager and shareholder, Kong Weixue is not a small figure in Danghe Pharmaceutical, so the standard of airport pick-up is naturally not much lower.

"We meet again, hello Mr. Kong." After the contract was signed, Lei Hao no longer had to show off his acting skills and showed his true colors. While walking, he talked about work with Kong Weixue: "Our project team will send a financial officer When personnel come to the company, according to the contract..."

"No problem. Danghe Pharmaceutical welcomes Mr. Lei's decision very much, and we will cooperate well." As it should be, Kong Weixue quickly agreed to Lei Hao's series of requests.

After getting in the car, Kong Weixue smiled again and said: "Mr. Lei is here by chance. Since the funding problem has been solved, the laboratory will screen the compounds that have been produced in the next few days. As long as the number of active compounds that appear reaches the expected number, you can This investment will not be lost.”

"Then I wish we will get rich together." After Lei Hao answered, he leaned on the car seat to rest, but he was thinking about the problem in his heart.

With the 40 million investment plus the 5% stock options, the success of Danghe Pharmaceutical will directly determine Lei Hao's profit and loss. Of course, he knows the focus of the company at this stage.

The cruelty of the pharmaceutical industry is no less cruel than that of the financial industry. According to data in undergraduate textbooks, each new drug costs an average of several hundred million US dollars from source research and development to Phase 3 clinical trials. If the valuation of Danghe Pharmaceutical is converted into US dollars, the figure is Just over 50 million.

Small pharmaceutical companies like Danghe Pharmaceutical are not capable of independently developing new drugs. They will only conduct pre-clinical research and sell the research after the results are produced. Pre-clinical research is roughly divided into four steps.

First, determine the drug target, that is, what you want to study. The second step is to synthesize the compound. The third step is to screen out active compounds from the synthesized compounds. The fourth step is to conduct drug evaluation, which is to conduct animal experiments or something. , it can be sold after completion.

Danghe Pharmaceutical currently has four compounds. Judging from the evaluation report, it is expected that two compounds will pass the final screening. Once the project is sold, everyone will sit down and divide the spoils, and then select the next project for research.

Lei Hao represents profit-seeking capital, and he won't care about the next project. When the experiment yields results, he will definitely sell the shares. I believe it will definitely be popular by then.

Surprisingly, Lei Hao waited for two days, and on Wednesday the 27th, he learned that the experiment was not going well. It was predicted that only one compound would eventually pass the experiment, or even none at all.

Lei Hao was immediately dumbfounded. He had already invested 40 million in real money on Tuesday. What experiment was not going well now? Is this a joke? What about doubling the promised amount?

"Mr. Lei, we're here." On the afternoon of the 27th, because the experiment was not going well, Danghe Pharmaceutical held a board meeting to prepare for making decisions. Lei Hao was also fortunate to attend his first board meeting.

According to the regulations of Danghe Pharmaceutical, natural persons and legal persons holding more than 10% of the shares automatically become board members. The Thunder No. 1 project team just meets this standard. As the actual person in charge of the project, Lei Hao is also qualified to represent Thunder No. 1 Attend meetings.

It's just that... the agreed-upon meeting to share the spoils turned into a negotiation to shirk the blame, and Lei Hao felt dumbfounded.

"Well, before entering the formal meeting, we would like to welcome the new director Mr. Lei Haolei." At 16:00, the chairman of Danghe Pharmaceutical said on the rostrum of the conference room: "The estimated annual income of Mr. Lei's asset management plan With a rate of over 200%, he can be said to be the famous God of Wealth in the securities industry."

"Bah bang bang..." Those who can participate in the board of directors are not poor people. They have contacted Lei Hao in the past two days in order to build a relationship and maybe have a chance to make a fortune together in the future.

After standing up and talking hypocritically with these people, Lei Hao sat back down and fixed his gaze on a middle-aged and elderly man with a wry smile on his lips.

If the man didn't say his age, his head of white hair might be misunderstood as being over sixty years old. However, Lei Hao read his information and knew that the man was actually only fifty-one years old. He was currently in charge of the research and development of Danghe Pharmaceutical. The name of the laboratory is Li Gaotang.

If anyone were to say that Danghe Pharmaceutical's turnaround might come to someone, Lei Hao would definitely vote for Li Miaotang. As a well-known scholar in the country, the latter's reputation and ability are well-known, but there is still some gap between him and the top of the pyramid.

As expected by Lei Hao, the directors all knew who should speak most at this time. Less than five minutes after the meeting started, Li Gaotang stood up and spoke.

"The success of drug research and development is a probabilistic event, including all its processes. If it is unsuccessful, even Chengren will not have a chance. Recently, our research and development is progressing smoothly..."

"Even if the medicine made from the remaining active compound is very unlikely to enter clinical trials, its cost and efficacy are destined to have a poor market prospect, so..."

After Li Gaotang talked about everything from the beginning to the current progress, there was an inexplicable brilliance in his eyes, and he said with a sincere tone: "I would like to apply for the investigation of compounds No. 03, 05 and 07. Experiment, I believe the probability of good results will not be too low."

There was some whispering in the conference room. Everyone, including Lei Hao, knew the reason why these three compounds were abandoned, and that was the cost.

The market for antihypertensive drugs is indeed large, but the prices are already there. The high cost of developing compounds proves that the cost of drugs is high. How to sell them? What's the value? Experiments require money, and the goal of capital is always to pursue profits. If you don’t have money to make, who will play with you?

Capital makes dreams come true, provided your dreams can create value for capital.

Looking at the brilliance in Li Moutang's eyes, Lei Hao seemed to see countless gold ingots waving.